Portia Hunidzarira
ORCID：0000-0001-6692-4378
发表论文 12 篇 · 总被引 821 次 · h-index 6
代表论文
- Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial (2022 · The Lancet · 被引 584)
- Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study (2021 · The Lancet HIV · 被引 112)
- Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084 (2021 · The Journal of Infectious Diseases · 被引 73)
- Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region (2023 · Journal of Global Health · 被引 19)
- Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial (2024 · PLoS Medicine · 被引 10)
- Cabotegravir for Prevention of HIV-1 in Women: Results From HPTN 084, a Phase III, Randomised Controlled Trial (2022 · SSRN Electronic Journal · 被引 9)